Trimethoprim-sulfamethoxazole in the treatment of infections of the ears, nose, and throat.
D000208:Acute Disease; D001424:Bacterial Infections / Q000188:drug therapy*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy*; D010404:Penicillin V / Q000009:adverse effects / Q000627:therapeutic use; D000039:Peritonsillar Abscess / Q000188:drug therapy; D010612:Pharyngitis / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014069:Tonsillitis / Q000188:drug therapy; D014295:Trimethoprim / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D014295:Trimethoprim; D013420:Sulfamethoxazole; D010404:Penicillin V